About This Deal

The Carlyle Group acquired Abingworth LLP for $186.2M base + up to $130M earnout, a transaction completed in August 2022, structured as Acquisition of 100% of the firm; cash plus stock plus performance earnout.

Abingworth LLP operates in Global Private Equity — Healthcare / life sciences, is based in London, United Kingdom. Carlyle acquired Abingworth, a London-based life-sciences investment firm managing nearly $2 billion in assets, to expand its global healthcare investment platform. The deal gave Carlyle rights to 15% of performance allocations on Abingworth's two most recent active funds. The acquisition closed August 1, 2022.

Expand Carlyle's healthcare franchise with dedicated life-sciences investment expertise and add roughly $2 billion of AUM.

Deal Terms

Acquirer
The Carlyle Group
Target
Abingworth LLP
Value
$186.2M base + up to $130M earnout
Date
August 2022
Type
Acquisition
Status
Official-source — no SEC filing

Transaction Details

Target HQ
London, United Kingdom
Segment
Global Private Equity — Healthcare / life sciences
Structure
Acquisition of 100% of the firm; cash plus stock plus performance earnout
Closed
August 1, 2022

Advisors

Advisory firms were not disclosed for this transaction.

Sources: Press release ↗ · SEC filing ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.